Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Correlation between the expression of P300 and clinicopathologic features in nasopharyngeal carcinomas

From: High expression of p300 is linked to aggressive features and poor prognosis of Nasopharyngeal Carcinoma

   P300 protein
  All cases Low expression High expression P value*
Sex     0.560
Female 59 25 (42.4%) 34 (57.6%)  
Male 150 57 (38.0%) 93 (62.0%)  
Age at diagnosis (years)     0.583
≤ 45 89 33 (37.1%) 56 (62.9%)  
> 45 120 49 (40.8%) 71 (59.2%)  
Histological classification (WHO)     0.363
Type II 54 24 (44.4%) 30 (55.6%)  
Type III 155 58 (37.4%) 97 (62.6%)  
T classification     0.000
1 26 19 (73.1%) 7 (26.9%)  
2 68 37 (54.4%) 31 (45.6%)  
3 69 17 (24.6%) 52 (75.4%)  
4 46 9 (19.6%) 37 (80.4%)  
N classification     0.024
0 40 23 (57.5%) 17 (42.5%)  
1 96 34 (35.4%) 62 (64.6%)  
2 51 15 (29.4%) 36 (70.6%)  
3 22 6 (27.3%) 16 (72.7%)  
Distant metastasis     0.021
0 158 69 (43.7%) 89 (56.3%)  
1 51 13 (25.5%) 38 (74.5%)  
Clinical stage     0.000
I 10 8 (80.0%) 2 (20.0%)  
II 55 37 (67.3%) 18 (32.7%)  
III 83 23 (27.7%) 60 (72.3%)  
IV 61 14 (23.0%) 47 (77.0%)  
  1. *Chi-square test; WHO, World Health Organization.